|
|
|
|
|
Legal status
Patent expired
| (51) | INT.CL. | C12N 15/67 | (2006.01) |
| C12N 5/10 | (2006.01) | ||
| C07K 14/47 | (2006.01) |
| (11) | Number of the document | 1105507 |
| (13) | Kind of document | T |
| (96) | European patent application number | 99942098.7 |
| Date of filing the European patent application | 1999-08-11 | |
| (97) | Date of publication of the European application | 2001-06-13 |
| (45) | Date of publication and mention of the grant of the patent | 2007-10-03 |
| (46) | Date of publication of the claims translation | 2008-01-25 |
| (86) | Number | PCT/US1999/018213 |
| Date | 1999-08-11 |
| (87) | Number | WO 2000/009714 |
| Date | 2000-02-24 |
| (30) | Number | Date | Country code |
| 96086 P | 1998-08-11 | US | |
| 371309 | 1999-08-10 | US |
| (72) |
HU, Shaw-Fen, Sylvia, US
GUDAS, Jean, Marie, US
BRANKOW, David, William, US
|
| (73) |
AMGEN INC.,
One Amgen Center Drive, Thousand Oaks, CA 91320-1799,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Dominančių baltymų superekspresija eukariotinėse ląstelėse, veikiant ciklino D1 superekspresija |
| OVEREXPRESSION OF DESIRED PROTEINS IN EUKARYOTIC CELLS MEDIATED BY CYCLIN D1 OVEREXPRESSION |
| Payment date | Validity (years) | Amount | |
| 2018-07-20 | 20 | 347.00 EUR |